ZA991325B - Novel group B streptococcus antigens. - Google Patents

Novel group B streptococcus antigens.

Info

Publication number
ZA991325B
ZA991325B ZA9901325A ZA991325A ZA991325B ZA 991325 B ZA991325 B ZA 991325B ZA 9901325 A ZA9901325 A ZA 9901325A ZA 991325 A ZA991325 A ZA 991325A ZA 991325 B ZA991325 B ZA 991325B
Authority
ZA
South Africa
Prior art keywords
novel group
streptococcus antigens
streptococcus
antigens
novel
Prior art date
Application number
ZA9901325A
Other languages
English (en)
Inventor
Clement Rioux
Denis Martin
Bernard R Brodeur
Josee Hamel
Isabelle Charlebois
Martine Boyer
Original Assignee
Biochem Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Vaccines Inc filed Critical Biochem Vaccines Inc
Publication of ZA991325B publication Critical patent/ZA991325B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA9901325A 1998-02-20 1999-02-18 Novel group B streptococcus antigens. ZA991325B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7542598P 1998-02-20 1998-02-20

Publications (1)

Publication Number Publication Date
ZA991325B true ZA991325B (en) 1999-08-20

Family

ID=22125658

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901325A ZA991325B (en) 1998-02-20 1999-02-18 Novel group B streptococcus antigens.

Country Status (22)

Country Link
US (4) US20030031682A1 (ru)
EP (3) EP2280072B1 (ru)
JP (2) JP4637350B2 (ru)
KR (1) KR100771148B1 (ru)
CN (2) CN1268745C (ru)
AP (1) AP2000001886A0 (ru)
AT (1) ATE347600T1 (ru)
AU (1) AU2505999A (ru)
CA (1) CA2321106C (ru)
CZ (1) CZ301056B6 (ru)
DE (1) DE69934299T2 (ru)
EA (1) EA200000860A1 (ru)
ES (2) ES2540281T3 (ru)
HU (1) HU228497B1 (ru)
ID (1) ID27482A (ru)
IL (3) IL137921A0 (ru)
NO (2) NO330491B1 (ru)
NZ (1) NZ529854A (ru)
OA (1) OA11686A (ru)
TR (1) TR200002437T2 (ru)
WO (1) WO1999042588A2 (ru)
ZA (1) ZA991325B (ru)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540281T3 (es) 1998-02-20 2015-07-09 Id Biomedical Corporation Of Quebec Antígenos de estreptococos del grupo B
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
JP2002531054A (ja) * 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド Ｂ群連鎖球菌由来の核酸およびタンパク質
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
EP1757696A3 (en) 1998-12-22 2008-10-29 Microscience Limited Group B streptococcus proteins, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
JP4749641B2 (ja) * 1999-08-25 2011-08-17 メディミューン，エルエルシー ワクチン用の肺炎球菌タンパク質の相同体および断片
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
EP1294771B1 (en) 2000-06-12 2008-10-29 University Of Saskatchewan Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
ATE343593T1 (de) * 2000-06-12 2006-11-15 Univ Saskatchewan Immunisation von milchvieh mit gapc protein gegen streptococcus infektion
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
EP1734050A3 (en) * 2000-06-12 2012-12-05 University Of Saskatchewan Immunization of dairy cattle with GapC protein against streptococcus infection
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
WO2002031156A2 (en) 2000-10-13 2002-04-18 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
CA2432525C (en) * 2000-12-21 2012-11-27 Shire Biochem Inc. Streptococcus pyogenes antigens and corresponding dna fragments
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
CA2475821C (en) * 2002-02-11 2011-12-13 Shire Biochem Inc. Group b streptococcus antigens
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
PL1648500T3 (pl) 2003-07-31 2014-12-31 Novartis Vaccines & Diagnostics Inc Kompozycje immunogenne dla Streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20090317420A1 (en) 2004-07-29 2009-12-24 Chiron Corporation Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
JP2008544949A (ja) 2004-10-08 2008-12-11 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 化膿性レンサ球菌のための免疫激性組成物および治療用組成物
JP2008530021A (ja) * 2005-02-08 2008-08-07 アイディー バイオメディカル コーポレイション オブ ケベック シー．オー．ビー． アズ グラクソスミスクライン バイオロジカルズ ノース アメリカ 医薬組成物
GB0605247D0 (en) * 2006-03-15 2006-04-26 Chiron Srl Compositions and methods for immunisation
RU2471497C2 (ru) 2007-09-12 2013-01-10 Новартис Аг Мутантные антигены gas57 и антитела против gas57
CN104292312A (zh) 2007-12-21 2015-01-21 诺华股份有限公司 链球菌溶血素o的突变形式
CN102304185A (zh) * 2011-09-02 2012-01-04 黑龙江八一农垦大学 预防奶牛乳房炎的融合蛋白sip-trap及制备方法和应用
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
CN1046291C (zh) 1993-03-19 1999-11-10 G·林达尔 Rib蛋白、其纯化方法、检测试剂盒及药物组合物
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
TW448184B (en) * 1994-11-01 2001-08-01 Kirin Brewery Peptide sequence that forms muscous glycoprotein chain and technique for producing thereof
US6420135B1 (en) * 1996-10-31 2002-07-16 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
ES2540281T3 (es) 1998-02-20 2015-07-09 Id Biomedical Corporation Of Quebec Antígenos de estreptococos del grupo B
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
JP2002531054A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド Ｂ群連鎖球菌由来の核酸およびタンパク質
EP1140157B1 (en) 1998-12-21 2009-02-18 MedImmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
TR200200633T2 (tr) 1998-12-23 2002-06-21 Shire Biochem Inc. Yeni streptococcus antijenleri
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
CA2475821C (en) 2002-02-11 2011-12-13 Shire Biochem Inc. Group b streptococcus antigens

Also Published As

Publication number Publication date
CZ20003054A3 (cs) 2001-03-14
ES2540281T3 (es) 2015-07-09
JP2002507396A (ja) 2002-03-12
US8580262B2 (en) 2013-11-12
AP2000001886A0 (en) 2000-09-30
NO20004161L (no) 2000-10-19
ID27482A (id) 2001-04-12
US8226953B2 (en) 2012-07-24
EP2280072B1 (en) 2015-03-25
HUP0102304A3 (en) 2008-03-28
DE69934299D1 (de) 2007-01-18
KR100771148B1 (ko) 2007-10-29
US20030031682A1 (en) 2003-02-13
IL190018A (en) 2011-07-31
IL137921A0 (en) 2001-10-31
EP1757697A2 (en) 2007-02-28
JP2009242403A (ja) 2009-10-22
NZ529854A (en) 2005-08-26
EP1757697A3 (en) 2007-05-30
EP1054971A2 (en) 2000-11-29
US20130095498A1 (en) 2013-04-18
CN1944652A (zh) 2007-04-11
EP2280072A3 (en) 2012-06-06
NO20101682L (no) 2000-10-19
AU2505999A (en) 1999-09-06
KR20010034518A (ko) 2001-04-25
CZ301056B6 (cs) 2009-10-29
ES2278436T3 (es) 2007-08-01
US20110182923A1 (en) 2011-07-28
CN1297482A (zh) 2001-05-30
US20030228323A1 (en) 2003-12-11
US7914794B2 (en) 2011-03-29
CN1268745C (zh) 2006-08-09
HUP0102304A1 (hu) 2001-10-28
HU228497B1 (en) 2013-03-28
TR200002437T2 (tr) 2000-11-21
WO1999042588A3 (en) 2000-03-23
JP4637350B2 (ja) 2011-02-23
IL190018A0 (en) 2008-08-07
DE69934299T2 (de) 2007-07-05
EP2280072A2 (en) 2011-02-02
WO1999042588A2 (en) 1999-08-26
CA2321106A1 (en) 1999-08-26
EP1054971B1 (en) 2006-12-06
NO330491B1 (no) 2011-05-02
IL137921A (en) 2008-06-05
EA200000860A1 (ru) 2001-10-22
NO20004161D0 (no) 2000-08-18
ATE347600T1 (de) 2006-12-15
CA2321106C (en) 2013-07-23
OA11686A (en) 2005-01-12

Similar Documents

Publication Publication Date Title
ZA991325B (en) Novel group B streptococcus antigens.
IL194230A0 (en) Novel streptococcus antigens
IL153558A0 (en) Streptococcus antigens
PL331585A1 (en) 2- 2,5-substituted phenylketoneoles
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA200101637B (en) Cyclone.
ZA9811939B (en) Novel macrolides.
ZA991272B (en) Novel thiobenzamides.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA978799B (en) Mycosis vaccine.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA978379B (en) Synchronizer.
ZA993123B (en) Trisresorcinyltriazines.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA97928B (en) Novel heteroaryl-oxazolidinones.
ZA987029B (en) Synchronizer.
GB9928678D0 (en) Streptococcus pneumoniae antigens
GB9825184D0 (en) Antigen
PL343547A1 (en) Streptococcus preparation
AU2003200963A1 (en) Group B Streptococcus Antigens
GB9800760D0 (en) Antigens
ZA989435B (en) Novel aryloxy-alkyl-dialkylamines.
GB9819015D0 (en) Antigens